WHO resumes HCQ trial

Tribune Web Desk

Updated At : 12:38 PM Jun 05, 2020 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

Tribune News Service
New Delhi, June 4

The WHO late last night revoked the temporary pause it had ordered last week on the hydroxychloroquine arm of the ongoing solidarity trial and announced the trial to resume.

The decision followed the recommendations of Data Safety Board of the WHO that reviewed mortality trends and concluded that there was no cause to modify any arm of the solidarity trial protocol, which is underway to test four drugs for efficacy against Covid-19.

Indian scientists stood vindicated after the WHO decision as the ICMR has decided to continue using HCQ for prevention of Covid in health workers and frontline staffers.

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles